Welcome to RLPSecurties

Stock Quotes	Board Of Directors	Income Statement	Directors Report	Change Name	Quarterly Results
High/Low	Share Holding	Balance Sheet	Auditors Report	Book Closure	Half Yearly Results
Company Profile	MF Holding	Cash Flow	Notes to Accounts	Dividend Details	Technical Chart
Locations	Investor Returns	Ratios	Banker's/Auditor's	ADR/GDR Prices	Peer Comparision

Alembic Pharmaceuticals Ltd.	Balance Sheet

NSE: APLLTDEQ BSE: 533573ISIN: INE901L01018INDUSTRY: Pharmaceuticals

BSE

Rs 784.70

Open: 790.35

Today's Range 776.00

807.25

NSE
Rs 784.10
-1.60 ( -0.20 %)

-1.75 ( -0.22 %)

Prev Close: 786.45

52 Week Range 635.30

1107.80

You can view the Balance Sheet for the last 5 years.

Market Cap. (Rs.)	15412.51 Cr.	P/BV	2.83	Book Value (Rs.)	277.42
52 Week High/Low (Rs.)	1108/636	FV/ML	2/1	P/E(X)	22.84
Bookclosure	29/07/2025	EPS (Rs.)	34.33	Div Yield (%)	0.00

(Rs. in Crs.)

Particulars	Mar 26	Mar 25	Mar 24	Mar 23	Mar 22
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	PR	AR	AR	AR	AR
FaceValue	2.00	2.00	2.00	2.00	2.00
No. of Equity Shares (in Lacs)	1965.50	1965.63	1965.63	1965.63	1965.63

EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31	39.31	39.31	39.31	39.31
Total Share Capital	39.31	39.31	39.31	39.31	39.31

Reserves and Surplus	5635.50	5151.64	4778.89	4331.16	5198.23
Total Reserves and Surplus	5635.50	5151.64	4778.89	4331.16	5198.23
Total Shareholders Funds	5674.81	5190.95	4818.20	4370.47	5237.54
Minority Interest	-5.83	-1.42	0.00	0.00	0.00

NON-CURRENT LIABILITIES
Long Term Borrowings	121.92	0.00	0.00	0.00	0.00
Other Long Term Liabilities	224.94	46.77	62.88	69.23	72.14
Long Term Provisions	152.91	124.31	109.51	106.20	95.82
Total Non-Current Liabilities	499.77	171.08	172.39	175.43	167.96

CURRENT LIABILITIES
Short Term Borrowings	1238.93	1195.57	430.45	635.87	629.99
Trade Payables	835.08	879.89	735.64	679.81	706.39
Other Current Liabilities	408.62	251.00	223.65	251.19	316.51
Short Term Provisions	111.21	85.87	65.25	70.06	63.64
Total Current Liabilities	2593.84	2412.33	1454.99	1636.93	1716.53

Total Capital And Liabilities	8762.59	7772.94	6445.58	6182.83	7122.03

ASSETS
NON-CURRENT ASSETS
Tangible Assets	2893.29	2523.53	2546.71	2398.45	1741.47
Intangible Assets	237.08	0.00	0.00	0.00	56.38
Capital Work-In-Progress	633.70	837.23	524.36	601.28	2205.79
Intangible Assets Under Development	0.00	0.00	0.00	0.00	98.44
Fixed Assets	3764.07	3360.76	3071.07	2999.73	4102.08
Non-Current Investments	140.88	127.21	93.02	96.33	118.40
Deferred Tax Assets [Net]	269.61	166.03	169.64	123.01	5.88
Other Non-Current Assets	15.43	31.15	33.29	53.74	34.88
Total Non-Current Assets	4189.99	3685.15	3367.02	3272.81	4261.24


CURRENT ASSETS
Inventories	2510.64	2288.14	1643.54	1475.27	1609.70
Trade Receivables	1466.30	1399.79	1024.84	1046.40	807.13
Cash And Cash Equivalents	202.70	90.10	126.57	82.27	69.43
OtherCurrentAssets	392.96	309.76	283.61	306.08	374.53
Total Current Assets	4572.60	4087.79	3078.56	2910.02	2860.79

Total Assets	8762.59	7772.94	6445.58	6182.83	7122.03

OTHER INFORMATION

CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	0.00	189.48	183.13	317.96	228.15

NON-CURRENT INVESTMENTS
Non-Current Investments Unquoted Book Value	0.00	25.72	68.61	71.20	63.69

Market

Derivatives

Mutual Fund

IPO

Quick Links

Alembic Pharmaceuticals Ltd.

Balance Sheet